Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Chemo Sensitization Before Hematopoietic Stem Cell Transplantation With a CXCR4 Antagonist in Patients With Acute Leukemia in Complete Remission: Pilot Study

Next Previous
Search
Trial Profile

Chemo Sensitization Before Hematopoietic Stem Cell Transplantation With a CXCR4 Antagonist in Patients With Acute Leukemia in Complete Remission: Pilot Study

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Jan 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Plerixafor (Primary) ; Busulfan; Cyclophosphamide
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use

Most Recent Events

  • 10 Jan 2020 Planned End Date changed from 1 Feb 2021 to 1 Nov 2021.
  • 10 Jan 2020 Planned primary completion date changed from 1 Feb 2020 to 1 Nov 2020.
  • 22 Apr 2019 Planned End Date changed from 1 Dec 2018 to 1 Feb 2021.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top